EyeCon 2026 Banner

Cataract

Latest News


CME Content


In patients who present with a cataract, certain histories should raise suspicion about existing damage to the posterior capsule or an increased risk for capsule rupture intraoperatively. Armed with that information, cataract surgeons can implement proper strategies for cataract removal and IOL implantation.

ACTIVATE System Control Software for the Stellaris Vision Enhancement System (“Stellaris”) and Stellaris PC (all Bausch + Lomb) includes 41 additional features and controls that collectively enhance the performance of the two systems and make them even easier to use.

A new digital image guidance platform (Surgical Navigation System, Cirle) for cataract surgery is an open-source system designed to enhance accurate execution of cataract incision placement, capsulorhexis sizing and centration, toric IOL alignment, and limbal relaxing incision placement.

The approval of intracameral phenylephrine and ketorolac injection 1%/0.3% (Omidria, Omeros Corp.) could have implications for preoperative management and potentially postoperative management as well, according to John R. Wittpenn, MD, Ophthalmic Consultants of Long Island. While the FDA study evaluated pain and maintenance of pupillary dilation pertaining to intraoperative use of Omidria, the findings hint at additional benefits.

With a wide array of IOL options available to their foreign colleagues, U.S. ophthalmologists eagerly await the approval and availability of additional lenses.

Planning for the fifth year of “Cataract Surgery: Telling It Like It Is,” set for Thursday, Jan. 15, to Sunday, Jan. 18, is well under way and meeting organizer Robert H. Osher, MD, promises “more faculty, more topics, and a lot more fireworks” for this latest gathering here.

Although infections caused by methicillin-resistant Staphylococcus aureus (MRSA) are a prominent concern for cataract surgeons, leading ophthalmologists discuss the pros and cons of performing universal MRSA screening to guide targeted prophylaxis.

Bausch + Lomb’s next-generation sub-micron gel formulation of loteprednol etabonate has been found to be statistically superior to placebo (vehicle gel) in eliminating inflammation and pain following cataract surgery by study day 8-the primary endpoints in the first phase III, multicenter, double-masked, vehicle-controlled, parallel-group study.

A femtosecond laser can create circular, well-centered capsulotomies to facilitate implantation of capsular tension rings and IOLs without decentration in pediatric patients with Marfan’s syndrome. Tim Schultz, MD, and H. Burkhard Dick, MD, of the University Eye Clinic Bochum, Bochum, Germany, described the case of a 10-year-old boy with Marfan’s syndrome.

The recent agreement between Valeant and Croma-which would provide for the distribution of Croma’s ophthalmology products in Western Europe-is expected to expand Bausch + Lomb’s (B + L) ophthalmic portfolio in the United States.

The European Society of Cataract and Refractive Surgeons (ESCRS) never fails to entice ophthalmology with cutting-edge technology, and the XXXII Congress in London has not disappointed attendees. This year’s congress has displayed a wide range of new technologies from cataract and refractive platforms to diagnostic units to surgical instruments. From all the equipment presented, IOL advances have again captured the attention of attendees.